| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 10/13/2009 | CA2220339C Toxin conjugates having a spacer comprising polyalkylene glycol and peptide |
| 10/13/2009 | CA2215933C Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents |
| 10/08/2009 | WO2009121210A1 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof |
| 10/08/2009 | CA2720306A1 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof |
| 10/07/2009 | EP2107374A1 Polypeptide for diagnosis of vaccination |
| 10/07/2009 | EP1312627B1 Polymers |
| 10/06/2009 | US7598081 Materials and procedures for the purification of cells |
| 10/06/2009 | US7598050 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein |
| 10/06/2009 | US7597887 Graft-versus-host disease; inhibit secretion of Interferon-gamma (IFN-?) by lymphocytes or other immune cells in a mammal; inflammatory bowel disease is Crohn's disease, ulcerative colitis, or ileitis; KIM-1 (Kidney Injury Molecule-1) |
| 10/01/2009 | US20090246753 Detection of Phage Amplification by SERS Nanoparticles |
| 10/01/2009 | US20090246211 Molecular constructs suitable for targeted conjugates |
| 09/30/2009 | CN101544696A Compound containing pigment epidermal derived factors and preparation method and application thereof |
| 09/29/2009 | US7595298 Ala-Arg-Nal-Cys-Tyr-Arg-Lys-DLys-Pro-Tyr-Arg-Cit-Cys-Arg; viricide; low cytotoxicity |
| 09/29/2009 | US7595166 Methods of screening modulators of T2R taste receptors |
| 09/29/2009 | US7595165 Contacting CD16 receptor-expressing cells in a reaction medium in the presence of the antibody with the antigen of the antibody, and measuring the quantity of at least one cytokine produced by the CD16 receptor-expressing cell; for increased antibody-dependent cellular cytotoxicity (ADCC) activity |
| 09/29/2009 | US7595052 Composition and method for the prevention and/or the treatment of allergy |
| 09/24/2009 | WO2009117531A1 Auristatin drug linker conjugates |
| 09/24/2009 | WO2009035540A3 Analogues of exendin-4 and exendin-3 |
| 09/24/2009 | WO2008143679A9 Nucleic acids and proteins and methods for making and using them |
| 09/24/2009 | US20090240038 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 09/24/2009 | CA2718942A1 Auristatin drug linker conjugates |
| 09/23/2009 | CN101538330A Modified product of reconstructed sea-anemone neurotoxin rhk2a, modifying method and application thereof |
| 09/22/2009 | US7592423 Globular adiponectin variants |
| 09/17/2009 | WO2009112497A1 Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation |
| 09/17/2009 | US20090234107 Protein-immobilized carrier |
| 09/17/2009 | US20090234100 Osteogenic compositions comprising an amiono acid sequence which is capable of being phosphorylated by camk2 |
| 09/17/2009 | US20090234070 Water-Soluble Polymer Alkanals |
| 09/17/2009 | US20090230322 Fluorescence based detection of substances |
| 09/17/2009 | CA2718245A1 Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation. |
| 09/17/2009 | CA2717699A1 Polyethylene glycolated lactoferrin complex and method of producing the same |
| 09/16/2009 | EP2101177A1 Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (EBV) reactivation |
| 09/16/2009 | EP2099819A1 Multimeric fc receptor polypeptides including a modified fc domain |
| 09/16/2009 | EP1519748B1 Microparticle with cd28-specific monoclonal antibodies |
| 09/15/2009 | US7589184 Stable protein storage and stable nucleic acid storage in recoverable form |
| 09/15/2009 | US7589179 Modified interleukin-7 (IL-7) polypeptides with reduced T-cell response |
| 09/15/2009 | US7589176 Antifungal polypeptides |
| 09/15/2009 | US7589174 GRP94-based compositions and methods of use thereof |
| 09/15/2009 | US7589172 PRO256 polypeptides |
| 09/15/2009 | US7588772 adeno-associated viral capsid proteins are generated by gene expressing from a genetic engineered vector; high transduction efficiency and low level of neutralization by the human immune system |
| 09/15/2009 | US7588765 Coupling a endotoxin (LPS) free polyfunctional polysaccharide with a polyfunctional carrier protein with quantitative yields; vaccine comprising a glycoconjugate antigen specific for Neisseria meningitidis |
| 09/15/2009 | CA2371462C Modified protein matrices |
| 09/11/2009 | WO2009109129A1 A new type of consensus interferon and preparation method thereof |
| 09/11/2009 | WO2009030065A8 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION |
| 09/11/2009 | WO2008029281A3 Labeling and detection of post translationally modified proteins |
| 09/10/2009 | US20090227516 Compound comprising an autoantigenic peptide and a carrier with a mhc binding motif |
| 09/10/2009 | US20090226891 Encoded solid supports for biological processing and assays using same |
| 09/10/2009 | US20090226442 RON antibodies and uses thereof |
| 09/10/2009 | US20090226438 Polypeptides and Antibodies |
| 09/10/2009 | US20090226421 Recombinant monovalent antibodies and methods for production thereof |
| 09/08/2009 | US7585941 Regulation of the MOR-1 splice variant activities may impact the physiologic process of analgesia |
| 09/08/2009 | US7585849 Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| 09/03/2009 | WO2009107771A1 Method for synthesis of peptide using gold-iron oxide composite nanoparticle |
| 09/03/2009 | WO2009105934A1 Monoclonal antibody anti-human rankl |
| 09/03/2009 | WO2009064321A3 Biomarker detection |
| 09/03/2009 | WO2008058963A8 Immobilization of membrane proteins onto supports via an amphiphile |
| 09/03/2009 | US20090221793 Process for preparing a pentopyranosyl nucleic acid conjugate |
| 09/03/2009 | US20090221487 Polyethlene glycol modifications of thymosin alpha-1 |
| 09/03/2009 | US20090221074 Conductive polymer matrix and device for use in the efficient isolation of preferential stem cells; permits the monitoring of cell binding to the solid matrix during the selection process, it is possible to obtain feedback information on the number of selected cells at any time |
| 09/03/2009 | US20090220529 Anticancer Drugs Conjugated to Antibody via an Enzyme Cleavable Linker |
| 09/03/2009 | CA2717276A1 Selenium containing modifying agents and conjugates |
| 09/02/2009 | EP1758937B1 Stable protein storage and stable nucleic acid storage in recoverable form |
| 09/02/2009 | EP1682655B1 Carbohydrate-binding modules |
| 09/02/2009 | EP1189645B1 Non-covalent bioconjugates useful for diagnosis and therapy |
| 09/01/2009 | US7582728 Microwave-assisted peptide synthesis |
| 09/01/2009 | US7582304 Immunizing an animal against Lyme disease by administering composition of at least two OspC polypeptides from Lyme Disease causing Borrelia comprising unlipidated and lipidated OspC polypeptides |
| 08/27/2009 | WO2009103199A1 A g-csf conjugate modified by water-soluble polymer |
| 08/27/2009 | WO2009078977A3 Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins |
| 08/27/2009 | US20090215996 Crosslinked polymers with amine binding groups |
| 08/27/2009 | US20090215992 Engineered multivalent and multispecific binding proteins; treatment of acute and chronic inflammatory, cancer |
| 08/27/2009 | US20090215711 Novel compositions and methods in cancer |
| 08/27/2009 | US20090215046 Novel nucleotide and amino acid sequences, and assays methods of use thereof for diagnosis of colon cancer |
| 08/27/2009 | US20090214438 Methods and compositions for the preparation and use of toxin conjugates |
| 08/26/2009 | EP2091550A2 Methods of promoting cardiac repair using growth factors fused to heparin binding sequences |
| 08/26/2009 | EP1891104B1 Solid phase bound thymosin alpha1 and its synthesis |
| 08/26/2009 | CN101514229A Human interferon alpha derivative and polyethylene glycol modified substance thereof |
| 08/26/2009 | CN101514223A Method for preparation of site-specific protein conjugates |
| 08/25/2009 | US7579443 Lyases; improved ethanol biosynthesis, stalk and nodal strength |
| 08/25/2009 | US7579441 Interleukins; immunoglobulins; for stimulating proliferation and/or development of hematopoietic cells in vitro and in vivo |
| 08/20/2009 | WO2009102782A2 Increasing efficiency of nucleic acid delivery in vivo using targeting conjugates |
| 08/20/2009 | WO2009101807A1 Peptide, use of the peptide, method for production of the peptide, solid support having the peptide immobilized thereon, and method for production of the solid support |
| 08/20/2009 | WO2007021841A9 Identification and engineering of antibodies with variant fc regions and methods of using same |
| 08/20/2009 | US20090209732 Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same |
| 08/20/2009 | US20090209453 Glycoprotein Hormone Analogs |
| 08/20/2009 | US20090209049 Use of metal complexes |
| 08/20/2009 | US20090208451 Halogen phosphonate monoesters |
| 08/19/2009 | EP2090590A1 Antibody against aflatoxins, support using the antibody, method of immunologically detecting aflatoxins and method of concentrating and purifying aflatoxins |
| 08/19/2009 | EP2090582A2 Binding molecules for human factor VIII and factor VIII-like proteins |
| 08/19/2009 | EP2089411A2 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 08/19/2009 | EP1435360B1 Novel peptide, novel adsorbent, adsorption unit and adsorption method |
| 08/19/2009 | EP1233987B1 Immobilized single domain antigen-binding molecules |
| 08/19/2009 | CN101512336A Stimulation of pancreatic beta cell proliferation |
| 08/19/2009 | CN101511869A Anti-MCP-1 antibodies, compositions, methods and uses |
| 08/19/2009 | CN101511859A Use of proteins and peptides of the TGF-beta superfamily for purification and therapeutic methods |
| 08/19/2009 | CN101511391A N-terminal derivatisation of proteins with polysaccharides |
| 08/19/2009 | CN101508735A Polyglycol modified bitter melon seed ribosome deactivation protein and preparation thereof |
| 08/18/2009 | US7576180 Opioid growth factor receptors |
| 08/18/2009 | US7575908 Immobilization method for producing active α1-acid glycoprotein |
| 08/18/2009 | US7575894 Human recombinant beta-interferon with improved solubility |
| 08/18/2009 | CA2328805C Enzyme-protein complex |
| 08/18/2009 | CA2054798C Hcv-specific peptides, agents therefor and the use thereof |